X
Dapagliflozin Improves Body Fat Patterning, and Hepatic and Pancreatic Fat in Patients With Type 2 Diabetes in North India.
Amerta Ghosh
| Koel Dutta
| Surya Prakash Bhatt
| Ritesh Gupta
| Kanika Tyagi
| Irshad Ahmad Ansari
| Vasantha Kumar Venugopal
| Harsh Mahajan
| Ravindra Mohan Pandey
| Shivam Pandey
| Anoop Misra
The Journal of clinical endocrinology and metabolism |
2022
Excess hepatic and pancreatic fat may contribute to hyperglycemia.
Pubmed ID: 35263436 RIS Download
Research resources used in this publication
None foundAdditional research tools detected in this publication
None foundAntibodies used in this publication
Associated grants
NonePublication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.
This is a list of tools and resources that we have found mentioned in this publication.
IMMULITE®/IMMULITE 1000 Insulin (antibody)
RRID:AB_2750939
This unknown targets Insulin
View all literature mentionsHuman Adiponectin ELISA Kit (antibody)
RRID:AB_2801457
This monoclonal targets Adiponectin
View all literature mentions
